Trials / Unknown
UnknownNCT04126941
Monocentric Study on the Use of Teriparatide in Children With hypoparathyroïdism
Bi-daily Injection of Subcutaneous Teriparatide in Children With Hypoparathyroidism: Single-center Experience
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Pediatric hypoparathyroidism is an orphan disease. Conventional management combines native and active vitamin D, calcium supplementation and sometimes phosphate binders, with the risk of long term hypercalciuria, nephrocalcinosis and further renal impairment. The use of teriparatide has been reported in adults (daily or bi-daily subcutaneous infusions) and in children (rather continuous subcutaneous infusion) as second-line therapy. The objective of this study is to obtain efficacy and safety data on the use of teriparatide in children with hypoparathyroidism to improve our knowledge of their management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Serum calcium concentrations results | To compare serum calcium concentrations results in patients with hypoparathyroidism before and three months after initiation of teriparatide therapy |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-06-01
- Completion
- 2020-12-01
- First posted
- 2019-10-15
- Last updated
- 2019-10-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04126941. Inclusion in this directory is not an endorsement.